TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ: 200230)

TELCON RF PHARMACEUTICAL. Revenue

TELCON RF PHARMACEUTICAL. had revenue of 7.16B KRW in the quarter ending September 30, 2024, a decrease of -19.03%. This brings the company's revenue in the last twelve months to 36.95B, up 12.50% year-over-year. In the year 2023, TELCON RF PHARMACEUTICAL. had annual revenue of 36.31B with 30.46% growth.

• Revenue (ttm): 36.95B
• Revenue Growth: +12.50%
• P/S Ratio: 1.48
• Revenue / Employee: 290.96M
• Employees: 127
• Market Cap: 56.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	36.31B	8.48B	30.46%
Dec 31, 2022	27.83B	-10.01B	-26.46%
Dec 31, 2021	37.84B	4.70B	14.18%
Dec 31, 2020	33.14B	-23.45B	-41.44%
Dec 31, 2019	56.59B	-1.12B	-1.94%